Sirtratumab vedotin
Gecertificeerd

Sirtratumab vedotin

Catalog #: HY-P99595-01
Maat: 1 mg
Droogijs Vereist

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

Sirtratumab vedotin (ASG15-ME) is an ADC composed of a SLITRK6-specific human gamma 2 antibody (Igγ2) conjugated to a small molecule microtubule disrupting agent, monomethyl auristatin E (MMAE) via a protease-cleavable linker[1].

CAS Number

1824663-83-3

Product Name Alternative

AGS15E; ASG-15ME; 1vcMMAE

UNSPSC

12352203

Target

Antibody-Drug Conjugates (ADCs)

Related Pathways

Antibody-drug Conjugate/ADC Related

Applications

Cancer-programmed cell death

Field of Research

Cancer

Purity

96.42

Solubility

H2O

Smiles

[Sirtratumabvedotin]

References & Citations

[1]Morrison K, et al. Development of ASG-15ME, a Novel Antibody-Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker. Mol Cancer Ther. 2016 Jun;15 (6) :1301-10.

Shipping Conditions

Dry Ice

Storage Conditions

-80°C, protect from light

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-P99595/Sirtratumab-vedotin-SDS-MedChemExpress.pdf

Scientific Category

ADC Related

Clinical Information

Phase 1

Beschrijving

Sirtratumab vedotin (ASG15-ME) is an ADC composed of a SLITRK6-specific human gamma 2 antibody (Igγ2) conjugated to a small molecule microtubule disrupting agen

Specificaties

ProductnaamSirtratumab vedotin
Categorie
Beschikbare grootte1 mg
CatalogusnummerHY-P99595-01